LIPOPOLYSACCHARIDE HETEROGENEITY IN ESCHERICHIA-COLI J5 VARIANTS - ANALYSIS BY FLOW-CYTOMETRY

被引:15
|
作者
EVANS, ME
POLLACK, M
KOLES, NL
HARDEGEN, NJ
PANOPOULOS, D
机构
[1] Department of Medicine, Uniformed Services University of the Health Sciences, F. Edward Hébert School of Medicine, Bethesda, MD
来源
JOURNAL OF INFECTIOUS DISEASES | 1992年 / 166卷 / 04期
关键词
D O I
10.1093/infdis/166.4.803
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A lipopolysaccharide O-side chain-producing phenotypic variant was isolated from a uridine 5'-diphosphogalactose 4-epimeraseless Escherichia coli J5 rough mutant strain by fluorescence-activated cell sorting with a monoclonal antibody (MAb) specific for the O-side chain of E. coli O111:B4 smooth parent lipopolysaccharide. The variant (J5-2) was recognized by both core- and O-side chain-specific MAbs, while the "original" rough mutant (J5-1) and smooth parent strains stained only with core- and O-side chain-specific MAb, respectively. J5-2 produced complete and incomplete (Rc chemotype) core and O polysaccharide in the presence of galactose. Three other E. coli J5 variants were either phenotypically similar to J5-1 (J5-UK) or distinct from J5-1 and J5-2 (J5-A, -B). The latter phenotype had a lower-molecular-weight core, compared with J5-1 and J5-2, and distinct MAb specificities. Various J5 phenotypes also differed in galactokinase levels, the ability to use galactose, and susceptibility to core-specific MAb binding on solid media. The J5-2 strain showed reciprocal changes in O-side chain and core expression during log-phase growth. E. coli J5 thus undergoes spontaneous alterations in lipopolysaccharide phenotype.
引用
收藏
页码:803 / 811
页数:9
相关论文
共 50 条
  • [1] HETEROGENEITY OF ESCHERICHIA-COLI J5 VACCINES
    APPELMELK, BJ
    RAPSON, NT
    VERWEIJVANVUGHT, AMJJ
    MAASKANT, JJ
    HEKKER, TAM
    PEERBOOMS, PGH
    MACLAREN, DM
    THIJS, LG
    [J]. LANCET, 1986, 2 (8518): : 1273 - 1274
  • [2] HETEROGENEITY OF ESCHERICHIA-COLI J5 STRAINS
    EVANS, ME
    POLLACK, M
    KOLES, N
    APPELMELK, BJ
    [J]. CLINICAL RESEARCH, 1990, 38 (02): : A393 - A393
  • [3] FATE OF THE LIPID-A AND POLYSACCHARIDE COMPONENTS OF ESCHERICHIA-COLI J5 LIPOPOLYSACCHARIDE FOLLOWING THE INGESTION OF ESCHERICHIA-COLI J5 BY MURINE MACROPHAGES INVITRO
    DUNCAN, RL
    ZIEGLER, HK
    MORRISON, DC
    [J]. REVIEWS OF INFECTIOUS DISEASES, 1984, 6 (04): : 573 - 574
  • [4] FLOW-CYTOMETRY ANALYSIS OF PLASMID AMPLIFICATION IN ESCHERICHIA-COLI
    SEO, JH
    SRIENC, F
    BAILEY, JE
    [J]. BIOTECHNOLOGY PROGRESS, 1985, 1 (03) : 181 - 188
  • [5] MEASUREMENT IN HUMAN-SERA OF ANTIBODIES TO LIPOPOLYSACCHARIDE OF ESCHERICHIA-COLI J5
    APPELMELK, B
    GRUTEKE, P
    VERWEIJVANVUGHT, M
    MAASKANT, J
    THIJS, B
    MACLAREN, D
    [J]. MICROBIAL PATHOGENESIS, 1987, 2 (05) : 391 - 393
  • [6] ANTIBODY-RESPONSE TO ESCHERICHIA-COLI J5 LIPOPOLYSACCHARIDE IN PATIENTS WITH BACTEREMIA
    BRAUNER, A
    KALLENIUS, G
    SVENSON, SB
    WRANGSELL, G
    WRETLIND, B
    [J]. MICROBIAL PATHOGENESIS, 1987, 2 (05) : 395 - 396
  • [7] FLOW-CYTOMETRY OF ESCHERICHIA-COLI FOR PROCESS MONITORING
    SCHEPER, T
    HITZMANN, B
    RINAS, U
    SCHUGERL, K
    [J]. JOURNAL OF BIOTECHNOLOGY, 1987, 5 (02) : 139 - 148
  • [8] IMMUNIZATION OF DAIRY-COWS WITH AN ESCHERICHIA-COLI J5 LIPOPOLYSACCHARIDE VACCINE
    TOMITA, GM
    TODHUNTER, DA
    HOGAN, JS
    SMITH, KL
    [J]. JOURNAL OF DAIRY SCIENCE, 1995, 78 (10) : 2178 - 2185
  • [9] DETECTION OF ESCHERICHIA-COLI IN BLOOD USING FLOW-CYTOMETRY
    MANSOUR, JD
    ROBSON, JA
    ARNDT, CW
    SCHULTE, TH
    [J]. CYTOMETRY, 1985, 6 (03): : 186 - 190
  • [10] PROPHYLACTIC ROLE FOR ANTIBODIES TO ESCHERICHIA-COLI J5
    GOULD, FK
    FREEMAN, R
    [J]. LANCET, 1987, 1 (8526): : 215 - 215